Translational Tissue Engineering (TTE) at the Medical University of Graz develops patient-derived models from tumor and normal tissues, including induced stem cells and organoids. These innovative in-vitro systems enable a deeper understanding of biological processes, the testing of novel therapies, and the advancement of personalized medicine. By integrating pathology, molecular biology, cell biology, and bioinformatics, TTE provides a central platform for translational research and biomedical innovation.
Head of research unit: Beate Rinner